Encompass Health Corporation (EHC) provides updates regarding Board refreshment, separation of home health and hospice business

Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, in response to recent discussions with stockholders, including JANA Partners LLC, today provided the following updates with respect to its previously disclosed Board refreshment process and planned separation of the Company's home health and hospice business, Enhabit.

The Company confirms that, in connection with its previously announced Board refreshment process, the size of the Board will consist of no more than 12 directors as of the conclusion of the 2022 Annual Meeting of Stockholders. The Company's slate of directors who will stand for election to the Board will be set forth in the Company's proxy statement materials when filed.

The Company continues to expect to complete the separation of Enhabit in the first half of 2022 via a spin-off. However, as Encompass Health proceeds with the separation process, our Board and management will assess any value-creating strategic opportunities and remain open to value-maximizing alternatives, including a sale or merger of Enhabit.

You May Also Be Interested In

• Wolfspeed (WOLF) Comments on Letter from JANA Partners
• Boxwood Partners Advises MASA Corporation on Sale of Print Division to Fortis Solutions Group
• Renovaro Biosciences (RENB) to Acquire Cyclomics